Combining cancer immunotherapy and targeted therapy

► Cancer-targeted therapies are being tested to synergize with tumor immunotherapy. ► Epigenetic modulators increase tumor antigen expression. ► BRAF inhibitors have paradoxical activation effects on lymphocytes. ► BRAF inhibitors can decrease cancer-released immune suppressive factors. ► PI3K/AKT pathway inhibitors can directly activate T memory cells.